ImmunoPrecise Antibodies
IPA
$0.63
Share price
6.14%
Change (1 day)
-76.02%
Change (1 year)
Categories
ImmunoPrecise Antibodies (IPA) - Total debt
Total debt on the balance sheet as of October 2024 : A$18.73 Million
According to ImmunoPrecise Antibodies's latest financial reports the company's total debt is A$18.73 Million. A company’s total debt is the sum of all current and non-current debts.
ImmunoPrecise Antibodies - Total debt on balance sheet (from 2002 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-04-30 | A$15.25 M | 89.39% |
| 2023-04-30 | A$8.05 M | 164.22% |
| 2022-04-30 | A$3.04 M | -15.8% |
| 2021-04-30 | A$3.62 M | -26.97% |
| 2020-04-30 | A$4.95 M | 60.78% |
| 2019-04-30 | A$3.08 M | -21.62% |
| 2018-04-30 | A$3.93 M | |
| 2017-04-30 | N/A | |
| 2015-12-31 | A$0.07 M | -5% |
| 2014-12-31 | A$0.07 M | -39.84% |
| 2013-12-31 | A$0.12 M | 167.52% |
| 2012-12-31 | A$0.04 M | 0.93% |
| 2011-12-31 | A$0.04 M | |
| 2002-12-31 | A$0 M |